HRSA discloses manufacturers approved for revised 340B rebate pilot

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 01 Oct, 16:08 UTC

Ten drugmakers will see 21 of their drugs move from upfront discounts to after-the-fact payments in the drug discount program at the start of next year, an expansion from the Trump administration’s first attempt at kickstarting a rebate pilot.

fintechscience

Sources

• T2HRSA discloses manufacturers approved for revised 340B rebate pilotBioPharma Dive / Healthcare Dive / MedTech Dive01 Oct, 16:08